Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ibandronate in Men With Osteoporosis
NCT00397839Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Ibandronate with Placebo (2 arms). Primary endpoint: Mean Percent Change in BMD of the Lumbar Spine From Baseline at 12 months. Started Jan 2007; status: completed.
02
Drugs
ibandronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00397839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397839.